Library / Laws / 114th / s / S. 2861 / Introduced in Senate
II
114th CONGRESS
2d Session
S. 2861
IN THE SENATE OF THE UNITED STATES
April 27, 2016
Mr. Rounds introduced the following bill; which was read twice and referred to the Committee on Armed Services
A BILL
To require the Secretary of Defense to review and
monitor prescribing practices at military treatment facilities of
pharmaceutical agents for the treatment of
post-traumatic stress.
1.
Short title
This Act may be cited as the Post-Traumatic Stress Disorder Medication Prescribing Improvement Act of 2016.
2.
Requirement to review and monitor prescribing practices at military treatment facilities of
pharmaceutical agents for treatment
of post-traumatic stress
(a)
In general
Not later than 180 days after the date of the enactment of this Act, the Secretary of Defense shall—
(1) conduct a comprehensive review of the prescribing practices at military treatment facilities of pharmaceutical agents for the treatment of post-traumatic stress;
(2) implement a process or processes to monitor the prescribing practices at military treatment facilities of pharmaceutical agents that are discouraged from use under the VA/DOD Clinical Practice Guideline for Management of Post-Traumatic Stress; and
(3) implement a plan to address any deviations from such guideline in prescribing practices of pharmaceutical agents for management of post-traumatic stress at such facilities.
(b)
Pharmaceutical agent defined
In this section, the term pharmaceutical agent has the meaning given that term in section 1074g(g) of title 10, United States Code.